These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10901524)

  • 1. Pre-existing elevated pulmonary vascular resistance: long-term hemodynamic follow-up and outcome of recipients after orthotopic heart transplantation.
    Tenderich G; Koerner MM; Stuettgen B; Mirow N; Arusoglu L; Morshuis M; Bairaktaris A; Minami K; Koerfer R
    J Cardiovasc Surg (Torino); 2000 Apr; 41(2):215-9. PubMed ID: 10901524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation.
    Erickson KW; Costanzo-Nordin MR; O'Sullivan EJ; Johnson MR; Zucker MJ; Pifarré R; Lawless CE; Robinson JA; Scanlon PJ
    J Heart Transplant; 1990; 9(5):526-37. PubMed ID: 2231091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-existing pulmonary hypertension in patients with end-stage heart failure: impact on clinical outcome and hemodynamic follow-up after orthotopic heart transplantation.
    Goland S; Czer LS; Kass RM; De Robertis MA; Mirocha J; Coleman B; Capelli C; Raissi S; Cheng W; Fontana G; Trento A
    J Heart Lung Transplant; 2007 Apr; 26(4):312-8. PubMed ID: 17403470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of milrinone in pre-transplant assessment of patients with congestive heart failure and pulmonary hypertension.
    Pamboukian SV; Carere RG; Webb JG; Cook RC; D'yachkova Y; Abel JG; Ignaszewski AP
    J Heart Lung Transplant; 1999 Apr; 18(4):367-71. PubMed ID: 10226902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the transpulmonary pressure gradient a predictor for mortality after orthotopic cardiac transplantation?
    Gorlitzer M; Ankersmit J; Fiegl N; Meinhart J; Lanzenberger M; Unal K; Dunkler D; Kilo J; Wolner E; Grimm M; Grabenwoeger M
    Transpl Int; 2005 Apr; 18(4):390-5. PubMed ID: 15773956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markers of pulmonary hypertension in potential candidates to heart transplantation.
    Wierzbicki K; Przybyłowski P; Sobczyk D; Konstanty J; Kapelak B; Drwiła R; Krochin M; Podolec P; Wójcik S; Marek G; Wróbel K; Piatek J; Rudziński P; Sadowski J
    Przegl Lek; 2006; 63(12):1263-8. PubMed ID: 17642136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The hemodynamics of the lesser circulation before and after heart transplantation in patients with dilated cardiomyopathy].
    Shumakov VI; Kormer AIa; Kozakov EN; Chestukhin VV; Shemakin SIu
    Grud Serdechnososudistaia Khir; 1993; (6):4-7. PubMed ID: 8312006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic sildenafil lowers transpulmonary gradient and improves cardiac output allowing successful heart transplantation.
    Jabbour A; Keogh A; Hayward C; Macdonald P
    Eur J Heart Fail; 2007; 9(6-7):674-7. PubMed ID: 17347040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Impact of pulmonary hypertension on early hemodynamics after orthotopic heart transplantation].
    Liu MZ; Wang JH; Du J; Huang J; Li LH
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2618-22. PubMed ID: 18162149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low doses of inhaled nitric oxide in heart transplant recipients.
    Auler Júnior JO; Carmona MJ; Bocchi EA; Bacal F; Fiorelli AI; Stolf NA; Jatene AD
    J Heart Lung Transplant; 1996 May; 15(5):443-50. PubMed ID: 8771498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis and predictors of pulmonary vascular resistance after cardiac transplantation.
    Bourge RC; Kirklin JK; Naftel DC; White C; Mason DA; Epstein AE
    J Thorac Cardiovasc Surg; 1991 Mar; 101(3):432-44; discussion 444-5. PubMed ID: 1999936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pulmonary hypertension on early hemodynamics, morbidity and mortality after orthotopic heart transplantation. A single center study.
    Bedanova H; Orban M; Vrsansky D; Spinarova L; Hude P; Krejci J; Ondrasek J; Nemec P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Mar; 157(1):35-40. PubMed ID: 23073529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience.
    Murali S; Kormos RL; Uretsky BF; Schechter D; Reddy PS; Denys BG; Armitage JM; Hardesty RL; Griffith BP
    Am Heart J; 1993 Oct; 126(4):896-904. PubMed ID: 8213447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium Nitroprusside in Patients With Mixed Pulmonary Hypertension and Left Heart Disease: Hemodynamic Predictors of Response and Prognostic Implications.
    Lim HS; Zaphiriou A
    J Card Fail; 2016 Feb; 22(2):117-24. PubMed ID: 26547011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of the pre-transplant diastolic pulmonary artery pressure-to-pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension.
    Tedford RJ; Beaty CA; Mathai SC; Kolb TM; Damico R; Hassoun PM; Leary PJ; Kass DA; Shah AS
    J Heart Lung Transplant; 2014 Mar; 33(3):289-97. PubMed ID: 24462554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study.
    von Scheidt W; Costard-Jaeckle A; Stempfle HU; Deng MC; Schwaab B; Haaff B; Naegele H; Mohacsi P; Trautnitz M;
    J Heart Lung Transplant; 2006 Sep; 25(9):1070-6. PubMed ID: 16962468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of treatment with sildenafil for secondary pulmonary hypertension in heart transplant candidates.
    Zakliczynski M; Maruszewski M; Pyka L; Trybunia D; Nadziakiewicz P; Przybylski R; Zembala M
    Transplant Proc; 2007 Nov; 39(9):2856-8. PubMed ID: 18022001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of reversible pulmonary hypertension on outcomes after heart transplantation.
    Drakos SG; Kfoury AG; Gilbert EM; Horne BD; Long JW; Stringham JC; Campbell BA; Renlund DG
    J Heart Lung Transplant; 2007 Apr; 26(4):319-23. PubMed ID: 17403471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiac catheterization and pulmonary vasoreactivity testing in children with idiopathic pulmonary arterial hypertension].
    Zhang C; Li Q; Liu T; Gu H
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):468-72. PubMed ID: 25190170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.